Demographic profile of 369 patients with AIDS-related lymphoma over different time intervals
. | 1982-1986 (%) . | 1987-1990 (%) . | 1991-1994 (%) . | 1995-1998 (%) . | Total (%) . | P value . |
---|---|---|---|---|---|---|
No. patients | 44 | 88 | 132 | 105 | 369 | |
Median age (y) | 40 | 36 | 38 | 39 | 38 | .18 |
Sex | .25 | |||||
Female | 0 (0) | 2 (2) | 6 (5) | 7 (7) | 15 (4) | |
Male | 44 (100) | 86 (98) | 126 (95) | 98 (93) | 354 (96) | |
Race | .001 | |||||
Caucasian | 33 (75) | 50 (57) | 64 (48) | 42 (40) | 189 (51) | * |
Hispanic | 7 (16) | 29 (33) | 51 (39) | 58 (55) | 145 (39) | † |
Black | 4 (9) | 4 (5) | 17 (13) | 5 (5) | 30 (8) | |
Asian | 0 (0) | 5 (6) | 0 (0) | 0 (0) | 5 (1) | |
Risk | .039 | |||||
MSM | 37 (84) | 67 (76) | 105 (80) | 69 (66) | 278 (75) | ‡ |
IDU ± MSM | 3 (7) | 7 (8) | 4 (3) | 3 (3) | 17 (5) | |
Hetero | 2 (5) | 4 (5) | 13 (10) | 19 (18) | 38 (10) | 1-153 |
Transfusion | 0 | 3 (3) | 1 (0.5) | 4 (4) | 8 (2) | |
Unknown | 2 (5) | 7 (8) | 9 (7) | 10 (10) | 28 (8) | |
KPS | .0008 | |||||
> 80% | 14 (32) | 28 (32) | 75 (57) | 45 (43) | 162 (44) | |
< 80% | 30 (68) | 60 (68) | 57 (43) | 60 (57) | 207 (56) | |
Prior OI1-154 | 14 (32) | 40 (45) | 58 (44) | 53 (50) | 165 (45) | .22 |
Prior KS1-154 | 2 (5) | 13 (15) | 11 (8) | 14 (13) | 40 (11) | .20 |
Median CD41-155 | 177 | 113 | 54 | 53 | 66 | .0006 |
Range | 0-1703 | 2-1927 | 0-710 | 0-700 | 0-1927 |
. | 1982-1986 (%) . | 1987-1990 (%) . | 1991-1994 (%) . | 1995-1998 (%) . | Total (%) . | P value . |
---|---|---|---|---|---|---|
No. patients | 44 | 88 | 132 | 105 | 369 | |
Median age (y) | 40 | 36 | 38 | 39 | 38 | .18 |
Sex | .25 | |||||
Female | 0 (0) | 2 (2) | 6 (5) | 7 (7) | 15 (4) | |
Male | 44 (100) | 86 (98) | 126 (95) | 98 (93) | 354 (96) | |
Race | .001 | |||||
Caucasian | 33 (75) | 50 (57) | 64 (48) | 42 (40) | 189 (51) | * |
Hispanic | 7 (16) | 29 (33) | 51 (39) | 58 (55) | 145 (39) | † |
Black | 4 (9) | 4 (5) | 17 (13) | 5 (5) | 30 (8) | |
Asian | 0 (0) | 5 (6) | 0 (0) | 0 (0) | 5 (1) | |
Risk | .039 | |||||
MSM | 37 (84) | 67 (76) | 105 (80) | 69 (66) | 278 (75) | ‡ |
IDU ± MSM | 3 (7) | 7 (8) | 4 (3) | 3 (3) | 17 (5) | |
Hetero | 2 (5) | 4 (5) | 13 (10) | 19 (18) | 38 (10) | 1-153 |
Transfusion | 0 | 3 (3) | 1 (0.5) | 4 (4) | 8 (2) | |
Unknown | 2 (5) | 7 (8) | 9 (7) | 10 (10) | 28 (8) | |
KPS | .0008 | |||||
> 80% | 14 (32) | 28 (32) | 75 (57) | 45 (43) | 162 (44) | |
< 80% | 30 (68) | 60 (68) | 57 (43) | 60 (57) | 207 (56) | |
Prior OI1-154 | 14 (32) | 40 (45) | 58 (44) | 53 (50) | 165 (45) | .22 |
Prior KS1-154 | 2 (5) | 13 (15) | 11 (8) | 14 (13) | 40 (11) | .20 |
Median CD41-155 | 177 | 113 | 54 | 53 | 66 | .0006 |
Range | 0-1703 | 2-1927 | 0-710 | 0-700 | 0-1927 |
MSM indicates men who have sex with men; IDU, injection drug use; Hetero, heterosexual risk factor for HIV; KPS, Karnofsky performance status; OI, opportunistic infection; KS, Kaposi sarcoma.
P value = .0007, comparing Caucasians versus all other races.
P value < .0001, comparing Hispanics versus all other races.
P value = .045, comparing MSM with all other HIV risk groups.
P value = .011, comparing heterosexual transmission with all other HIV risk groups.
Patients without a diagnosis of OI or KS prior to development of lymphoma presented with lymphoma as the first AIDS-defining condition.
CD4 count at time of diagnosis of AIDS-related lymphoma.